The impact of insurance type on listing status and wait‐list mortality of patients with left ventricular assist devices as bridge to transplantation

Abstract Aims Adequate health insurance coverage is necessary for heart transplantation (HT) candidates. Prior studies have suggested inferior outcomes post HT with public health insurance. We sought to evaluate the effects of insurance type on transplantation rates, listing status and mortality pri...

Full description

Saved in:
Bibliographic Details
Main Authors: Alexandros Briasoulis, Emmanuel Akintoye, Chakradhari Inampudi, Aziz Hammoud, Paulino Alvarez
Format: Article
Language:English
Published: Wiley 2020-06-01
Series:ESC Heart Failure
Subjects:
Online Access:https://doi.org/10.1002/ehf2.12655
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832544433713709056
author Alexandros Briasoulis
Emmanuel Akintoye
Chakradhari Inampudi
Aziz Hammoud
Paulino Alvarez
author_facet Alexandros Briasoulis
Emmanuel Akintoye
Chakradhari Inampudi
Aziz Hammoud
Paulino Alvarez
author_sort Alexandros Briasoulis
collection DOAJ
description Abstract Aims Adequate health insurance coverage is necessary for heart transplantation (HT) candidates. Prior studies have suggested inferior outcomes post HT with public health insurance. We sought to evaluate the effects of insurance type on transplantation rates, listing status and mortality prior to HT. Methods and results Patients ≥18 years old with a left ventricular assist device implanted and listed with 1A status were identified in the United Network for Organ Sharing registry between January 2010 and December 2017, with follow‐up through March 2018. Patients were grouped based on the type of insurance private/self‐pay (PV), Medicare (MC), and Medicaid (MA) at the time of listing. We conducted multivariable competing risks regression analysis on listing status and mortality on the waiting list, stratified by insurance type at the time of listing. We identified 2604 patients listed in status 1A (PV: 51.4%, MC: 32.1%, and MA: 16.5%). MA patients were younger (43.5 vs. 56.4 for MC vs. 51.5 for PV, P < 0.001) and less frequently White (P < 0.001). The cumulative incidence of HT did not differ among the three insurance types (PV: 74.8%, MC 76.3%, and MA 71.1%, P = 0.14). The cumulative mortality on the waiting list prior to HT was not different among groups (PV: 29.3%, MC 26.3%, and MA 21.8%, P = 0.94). Μore patients with MA were removed from the list because of improvement of their condition (MA 40.3% vs. MC 28.3% and PV 32.8%). Conclusions We did not detect any disparities in listing status and mortality among different insurance types.
format Article
id doaj-art-c61a628da7314e61a8b04d99d7d6c178
institution Kabale University
issn 2055-5822
language English
publishDate 2020-06-01
publisher Wiley
record_format Article
series ESC Heart Failure
spelling doaj-art-c61a628da7314e61a8b04d99d7d6c1782025-02-03T10:25:46ZengWileyESC Heart Failure2055-58222020-06-017380481010.1002/ehf2.12655The impact of insurance type on listing status and wait‐list mortality of patients with left ventricular assist devices as bridge to transplantationAlexandros Briasoulis0Emmanuel Akintoye1Chakradhari Inampudi2Aziz Hammoud3Paulino Alvarez4Division of Cardiovascular Diseases, Section of Heart Failure and Transplant University of Iowa Hospitals and Clinics Iowa City IA USADivision of Cardiovascular Diseases, Section of Heart Failure and Transplant University of Iowa Hospitals and Clinics Iowa City IA USADivision of Cardiovascular Diseases, Section of Heart Failure and Transplant University of Iowa Hospitals and Clinics Iowa City IA USADivision of Cardiovascular Diseases, Section of Heart Failure and Transplant University of Iowa Hospitals and Clinics Iowa City IA USADivision of Cardiovascular Diseases, Section of Heart Failure and Transplant University of Iowa Hospitals and Clinics Iowa City IA USAAbstract Aims Adequate health insurance coverage is necessary for heart transplantation (HT) candidates. Prior studies have suggested inferior outcomes post HT with public health insurance. We sought to evaluate the effects of insurance type on transplantation rates, listing status and mortality prior to HT. Methods and results Patients ≥18 years old with a left ventricular assist device implanted and listed with 1A status were identified in the United Network for Organ Sharing registry between January 2010 and December 2017, with follow‐up through March 2018. Patients were grouped based on the type of insurance private/self‐pay (PV), Medicare (MC), and Medicaid (MA) at the time of listing. We conducted multivariable competing risks regression analysis on listing status and mortality on the waiting list, stratified by insurance type at the time of listing. We identified 2604 patients listed in status 1A (PV: 51.4%, MC: 32.1%, and MA: 16.5%). MA patients were younger (43.5 vs. 56.4 for MC vs. 51.5 for PV, P < 0.001) and less frequently White (P < 0.001). The cumulative incidence of HT did not differ among the three insurance types (PV: 74.8%, MC 76.3%, and MA 71.1%, P = 0.14). The cumulative mortality on the waiting list prior to HT was not different among groups (PV: 29.3%, MC 26.3%, and MA 21.8%, P = 0.94). Μore patients with MA were removed from the list because of improvement of their condition (MA 40.3% vs. MC 28.3% and PV 32.8%). Conclusions We did not detect any disparities in listing status and mortality among different insurance types.https://doi.org/10.1002/ehf2.12655LVADInsuranceHeart transplantation
spellingShingle Alexandros Briasoulis
Emmanuel Akintoye
Chakradhari Inampudi
Aziz Hammoud
Paulino Alvarez
The impact of insurance type on listing status and wait‐list mortality of patients with left ventricular assist devices as bridge to transplantation
ESC Heart Failure
LVAD
Insurance
Heart transplantation
title The impact of insurance type on listing status and wait‐list mortality of patients with left ventricular assist devices as bridge to transplantation
title_full The impact of insurance type on listing status and wait‐list mortality of patients with left ventricular assist devices as bridge to transplantation
title_fullStr The impact of insurance type on listing status and wait‐list mortality of patients with left ventricular assist devices as bridge to transplantation
title_full_unstemmed The impact of insurance type on listing status and wait‐list mortality of patients with left ventricular assist devices as bridge to transplantation
title_short The impact of insurance type on listing status and wait‐list mortality of patients with left ventricular assist devices as bridge to transplantation
title_sort impact of insurance type on listing status and wait list mortality of patients with left ventricular assist devices as bridge to transplantation
topic LVAD
Insurance
Heart transplantation
url https://doi.org/10.1002/ehf2.12655
work_keys_str_mv AT alexandrosbriasoulis theimpactofinsurancetypeonlistingstatusandwaitlistmortalityofpatientswithleftventricularassistdevicesasbridgetotransplantation
AT emmanuelakintoye theimpactofinsurancetypeonlistingstatusandwaitlistmortalityofpatientswithleftventricularassistdevicesasbridgetotransplantation
AT chakradhariinampudi theimpactofinsurancetypeonlistingstatusandwaitlistmortalityofpatientswithleftventricularassistdevicesasbridgetotransplantation
AT azizhammoud theimpactofinsurancetypeonlistingstatusandwaitlistmortalityofpatientswithleftventricularassistdevicesasbridgetotransplantation
AT paulinoalvarez theimpactofinsurancetypeonlistingstatusandwaitlistmortalityofpatientswithleftventricularassistdevicesasbridgetotransplantation
AT alexandrosbriasoulis impactofinsurancetypeonlistingstatusandwaitlistmortalityofpatientswithleftventricularassistdevicesasbridgetotransplantation
AT emmanuelakintoye impactofinsurancetypeonlistingstatusandwaitlistmortalityofpatientswithleftventricularassistdevicesasbridgetotransplantation
AT chakradhariinampudi impactofinsurancetypeonlistingstatusandwaitlistmortalityofpatientswithleftventricularassistdevicesasbridgetotransplantation
AT azizhammoud impactofinsurancetypeonlistingstatusandwaitlistmortalityofpatientswithleftventricularassistdevicesasbridgetotransplantation
AT paulinoalvarez impactofinsurancetypeonlistingstatusandwaitlistmortalityofpatientswithleftventricularassistdevicesasbridgetotransplantation